Skip to main content
OpenTrials
Completed

NCT Number: NCT04331171

Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage

A coronavirus pandemic began on 12/31/2020 with the first Chinese patient. As of 3/16/2020, the epidemic affects more than 100 countries with 169,000 official infections and 6,500 deaths. This virus causes a pathology ranging from simple flu symptoms in 80% of cases to acute respiratory distress syndromes requiring resuscitation in 5% of cases and a death rate of 1.4 to 4% of cases.

The arrival in France on 02/25/2020 with an exponential development of the infection (more than 5,000 cases on 03/15/2020) was accompanied by an unprecedented number of calls to the French emergency service call number (15) of worried patients with overload and sometimes saturation of the service that can impact calls and the care of patients really recovering from an emergency.

We previously developed a Moovcare® web application which showed a 7 months survival benefit by early detection of relapsed lung cancer based on the reporting of patient symptoms analyzed by a validated algorithm in 300 patients and 1 trial randomized. Another application for detecting and monitoring chemo-induced febrile aplasia appears to show a reduction in the number of hospitalizations for sepsis. Finally, Smokecheck, a self-assessment application for symptoms by smokers, has shown that it improves the detection of symptomatic operable bronchial cancers (9 to 24%, p = 0.04).

The web application https://www.maladiecoronavirus.fr/ was developed with a group of physicians from the Institut Pasteur, Hospitals group of Paris, Hospitals of Lille and Rennes and the ILC Jean Bernard in Le Mans. It makes it possible to guide symptomatic patients and patients who wishing to know what to do (call their general practitioner, teleconsultation, or call emergency service) based on symptoms and predictive factors of severity.

Following the availability of this new tool, we want to assess the impact of the application on the number and relevance of calls to emergency service.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

All French Emergency services

Le Mans, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All users of the https://www.maladiecoronavirus.fr/ application over the age of 18

Exclusion criteria

  • not applicable

Treatment and study plan

Web application users

Device

questionnaire of comorbidity and symptoms completed by the patient on his smartphone

Primary outcomes

  1. To assess of the evolution of the number of calls to Emergency service within 12 days after the launch of the application https://www.maladiecoronavirus.fr/

    Time frame: 12 days

    Number of calls to Emergency service after the launch of web application comparded to the days before

  2. To assess of the evolution of the proportion of relevant calls to Emergency service within 12 days after the launch of the application https://www.maladiecoronavirus.fr/

    Time frame: 12 days

    Number of relevants calls to Emergency service after the launch of web application comparded to the days before

Secondary outcomes

  1. To assess the evolution over time of the COVID 19 epidemic

    Time frame: 3 months

    the symptoms collected by the application

  2. To assess the evolution over space of the COVID 19 epidemic

    Time frame: 3 months

    the symptoms collected by the application according to ZIP code

  3. To assess symptoms

    Time frame: 3 months

    Descriptive analysis of symptoms collected by web-application

  4. To assess the users population

    Time frame: 3 months

    Descriptive analysis of data collected by web-application

Sponsors and collaborators

Lead sponsor

Weprom

Other

Collaborators

  • Assistance Publique - Hôpitaux de Paris
  • DOCAPOST
  • Direction Générale de l'Offre de Soins
  • Institut Pasteur

Registry information

Acronym: COVID CALL 15

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Apr 2, 2020
Registry last updated
Apr 8, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.